Resebidrag Eureka, Zurich, Schweiz. 10th Swiss Scandinavian Bio Business Seminar
| Reference number | |
| Coordinator | Alzinova AB |
| Funding from Vinnova | SEK 8 000 |
| Project duration | February 2016 - March 2016 |
| Status | Completed |
Important results from the project
The purpose of the meeting was to communicate abot Alzinova and to better understand how we are percieved. Our goal was to meet at least five one-to-one that would be possible to follow up. We made a pitch to the whole auditorium. Further we met 10 companies one-to-one, of which one was very interested in our technology. This company has high interest to invest in Alzheimer therapy. Among the other one-to-ones, five are of the kind we will continue discussions because of mutual interest.
Expected long term effects
We are very pleased with the results of both the pitch and the one-to-ones, as we got further introductions into one very interesting company. We are continuing with this person and its team and plan the next steps to take. We will also continue the discussions with the other five companies who were interested to cooperate with us.
Approach and implementation
The set up with this much smaller meeting with Swiss and Scandinavian companies is very attractive. It is much easier to have contacts as competition in each therapeutic area and with time is less. The downside is that the small format makes it impossible to meet as many. In conclusion this is a very valuable complement to the large congresses. For us it is a great advantage that our unique features are easier to communicate, which was also possible to see.